Literature DB >> 25997728

Current radiosynthesis strategies for 5-HT2A receptor PET tracers.

Matthias M Herth1,2, Gitte M Knudsen1.   

Abstract

Serotonin 2A receptors have been implicated in various psychophysiological functions and disorders such as depression, Alzheimer's disease, or schizophrenia. Therefore, neuroimaging of this specific receptor is of significant clinical interest, and it is not surprising that many attempts have been made to develop a suitable 5-HT2A R positron emission tomography-tracer. In this review, we give an overview on the precursor, reference compound synthesis, and the preparation of promising 5-HT2A R radiopharmaceuticals applied in positron emission tomography. We also highlight possible learning outcomes that can be made from these tracer development processes.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  (R)-[18F]MH.MZ; 5-HT2A; PET; [11C]Cimbi-36; [11C]MDL 100907; [18F]MDL 100907 [18F]altanserin; [18F]MH.MZ; [18F]RP62203; [18F]deuteroaltanserin; [18F]fananserin; tracer development

Mesh:

Substances:

Year:  2015        PMID: 25997728     DOI: 10.1002/jlcr.3288

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  6 in total

1.  In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.

Authors:  Jaya Prabhakaran; Kiran Kumar Solingapuram Sai; Francesca Zanderigo; Harry Rubin-Falcone; Matthew J Jorgensen; Jay R Kaplan; Katharine I Tooke; Akiva Mintz; J John Mann; J S Dileep Kumar
Journal:  Bioorg Med Chem Lett       Date:  2016-11-16       Impact factor: 2.823

2.  Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain.

Authors:  Vasko Kramer; Agnete Dyssegaard; Jonathan Flores; Cristian Soza-Ried; Frank Rösch; Gitte Moos Knudsen; Horacio Amaral; Matthias M Herth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

Review 3.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

4.  Automated synthesis of (R)-[18 F]MH.MZ on the iPhase Flexlab reaction platform.

Authors:  Adam J Rosenberg; Yiu-Yin Cheung; Fei Liu; Todd E Peterson; James Silverman; Ciaran M Considine; Daniel O Claassen
Journal:  J Labelled Comp Radiopharm       Date:  2022-05-06       Impact factor: 1.949

5.  Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification.

Authors:  Giuseppe Floresta; Vincenzo Abbate
Journal:  RSC Adv       Date:  2021-04-20       Impact factor: 3.361

6.  Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging.

Authors:  Glenn Pauwelyn; Lise Vlerick; Robrecht Dockx; Jeroen Verhoeven; Andre Dobbeleir; Tim Bosmans; Kathelijne Peremans; Christian Vanhove; Ingeborgh Polis; Filip De Vos
Journal:  BMC Vet Res       Date:  2019-11-21       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.